Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1

de la Chapelle, A.

Beighton, P., & Beighton, G. (1997) · Springer eBooks · doi:10.1007/978-1-4471-0925-9_118 · Cited by 3,165

Hereditary Colorectal Cancer

Lynch, H. T., & de la Chapelle, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra012242 · Cited by 2,240

Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma

Herman, J. G., Umar, A., Polyák, K., Graff, J. R., Ahuja, N., Issa, J. J., Markowitz, S. D., Willson, J. K. V., Hamilton, S. R., Kinzler, K. W., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6870 · Cited by 1,887

Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines.

Kane, M., Loda, M. F., Gaida, G. M., Lipman, J., Mishra, R., Goldman, H., Jessup, J. M., & Kolodner, R. D. (1997) · PubMed · Cited by 1,476

Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA

Yu, W., Gius, D. R., Onyango, P. O., Muldoon‐Jacobs, K., Karp, J. E., Feinberg, A. P., & Cui, H. (2008) · Nature · doi:10.1038/nature06468 · Cited by 801

Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease

Tufarelli, C., Stanley, J. A. S., Garrick, D., Sharpe, J. A., Ayyub, H., Wood, W. G., & Higgs, D. R. (2003) · Nature Genetics · doi:10.1038/ng1157 · Cited by 547

Germline epimutation of MLH1 in individuals with multiple cancers

Suter, C. M., Martin, D. I. K., & Ward, R. L. (2004) · Nature Genetics · doi:10.1038/ng1342 · Cited by 475

Inheritance of a Cancer-Associated MLH1 Germ-Line Epimutation

Hitchins, M. P., Wong, J. J. L., Suthers, G., Suter, C. M., Martin, D. I. K., Hawkins, N. J., & Ward, R. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064522 · Cited by 409

Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer

Chan, T. L., Yuen, S. T., Kong, C. K., Chan, Y. W., Chan, A. S., Ng, W. F., Tsui, W. Y., Lo, M. W., Tam, W. Y., Li, V. S., et al. (2006) · Nature Genetics · doi:10.1038/ng1866 · Cited by 324

New perspectives on connecting messenger RNA 3′ end formation to transcription

Proudfoot, N. J. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.03.007 · Cited by 285

Gastrointestinal polyposis with associated cutaneous manifestations

Duarte, M., & Milikowski, C. (2021) · Pathology · doi:10.1016/j.pathol.2021.08.009 · Cited by 17

Structural Variation at a Disease Mutation Hotspot: Strategies to Investigate Gene Regulation and the 3D Genome

Boyling, A., Pérez‐Siles, G., & Kennerson, M. L. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.842860 · Cited by 15

Gastric and duodenal cancer in individuals with Lynch syndrome: a nationwide cohort study

Caspers, I. A., Eikenboom, E. L., López‐Yurda, M., van Grieken, N. C. T., Bisseling, T. M., Dekker, E., Bastiaansen, B. A. J., Cats, A., & van Leerdam, M. E. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102494 · Cited by 14

Micromanaging the Classification of Colon Cancer: The Role of the microRNAome

Vilar, E., Tabernero, J. M., & Gruber, S. B. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2440 · Cited by 14

Genomic diversity of colorectal cancer: Changing landscape and emerging targets

Ahn, D. H., Ciombor, K. K., Mikhail, S., & Bekaii‐Saab, T. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i25.5668 · Cited by 14

Somatic mutational signatures in polyposis and colorectal cancer

Grolleman, J. E., Díaz‐Gay, M., Franch‐Expósito, S., Castellvı́-Bel, S., & de Voer, R. M. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.05.002 · Cited by 13

Enteroids expressing a disease-associated mutant of EpCAM are a model for congenital tufting enteropathy

Das, B., Okamoto, K., Rabalais, J., Kozan, P. A., Marchelletta, R. R., McGeough, M. D., Durali, N., Go, M., Barrett, K. E., Das, S., et al. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00098.2019 · Cited by 13

The spectrum of Lynch syndrome-associated germ-line mutations in Russia

Yanus, G. A., Laidus, T. A., Iyevleva, A. G., Kornilov, A. V., Suspitsin, E. N., Kuligina, E. S., Ivantsov, A. O., Алексахина, С. Н., Sokolova, T. N., Соколенко, А. П., et al. (2019) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2019.103753 · Cited by 13

A review of computational algorithms for CpG islands detection

Tahir, R. A., Zheng, D., Nazir, A., & Qing, H. (2019) · Journal of Biosciences · doi:10.1007/s12038-019-9961-8 · Cited by 14

Somatic mutation profiles as molecular classifiers of ulcerative colitis‐associated colorectal cancer

Mäki‐Nevala, S., Ukwattage, S., Olkinuora, A. P., Almusa, H., Ahtiainen, M., Ristimaki, A. P., Seppälä, T. T., Lepistö, A., Mecklin, J., & Peltomäki, P. (2021) · International Journal of Cancer · doi:10.1002/ijc.33492 · Cited by 14

Incorporating Immunotherapy in the Management of Gastric Cancer: Molecular and Clinical Implications

Agnarelli, A., Vella, V., Samuels, M. E., Papanastasopoulos, P., & Giamas, G. (2022) · Cancers · doi:10.3390/cancers14184378 · Cited by 14

Contributions of molecular analysis to the diagnosis and treatment of gastrointestinal neoplasms

Bellizzi, A. M. (2013) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2013.11.001 · Cited by 14

Systematic Study on Genetic and Epimutational Profile of a Cohort of Amsterdam Criteria-Defined Lynch Syndrome in Singapore

Liu, Y., Chew, M. H., Goh, X. W., Tan, S., Loi, C. T., Tan, Y. M., Law, H. Y., Koh, P. K., & Tang, C. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094170 · Cited by 14

Disruption of a −35 kb Enhancer Impairs CTCF Binding and MLH1 Expression in Colorectal Cells

Liu, Q., Thoms, J. A. I., Nunez, A. C., Huang, Y., Knezevic, K., Packham, D., Poulos, R. C., Williams, R., Beck, D., Hawkins, N. J., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3678 · Cited by 14

Rare loss of function variants in candidate genes and risk of colorectal cancer

NHLBI GO Exome Sequencing Project, Rosenthal, E. A., Shirts, B. H., Amendola, L. M., Horike-Pyne, M. J., Robertson, P. D., Hisama, F. M., Bennett, R. L., Dorschner, M. O., Nickerson, D. A., et al. (2018) · Human Genetics · doi:10.1007/s00439-018-1938-4 · Cited by 14

Biallelic EPCAM deletions induce tissue-specific DNA repair deficiency and cancer predisposition

Forster, V. J., Aronson, M. D., Zhang, C., Chung, J., Sudhaman, S., Galati, M. A., Kelly, J., Negm, L., Ercan, A. B., Stengs, L. K., et al. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00537-6 · Cited by 13

Allele-specific gene expression and epigenetic modifications and their application to understanding inheritance and cancer

Lee, M. P. (2012) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2012.02.007 · Cited by 15

The revised Bethesda guidelines: extent of utilization in a university hospital medical center with a cancer genetics program

Mukherjee, A., McGarrity, T. J., Ruggiero, F. M., Koltun, W. A., McKenna, K. J., Poritz, L. S., & Baker, M. J. (2010) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-8-9 · Cited by 13

Childhood cancers in families with and without Lynch syndrome

Heath, J. A., Reece, J. C., Buchanan, D. D., Casey, G., Durno, C. A., Gallinger, S., Haile, R. W., Newcomb, P. A., Potter, J. D., Thibodeau, S. N., et al. (2015) · Familial Cancer · doi:10.1007/s10689-015-9810-3 · Cited by 13

Understanding Cancer Through the Lens of Epigenetic Inheritance, Allele-Specific Gene Expression, and High-Throughput Technology

Lee, M. P. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00794 · Cited by 13

Whole-Genome Profiles of Malay Colorectal Cancer Patients with Intact MMR Proteins

Juhari, W., Noordin, K. B. A. A., Zakaria, A., Rahman, W., Mokhter, W., Hassan, M., Sidek, A. S. M., & Zilfalil, B. (2021) · Genes · doi:10.3390/genes12091448 · Cited by 10

Evaluating Multiple Next-Generation Sequencing–Derived Tumor Features to Accurately Predict DNA Mismatch Repair Status

Walker, R., Georgeson, P., Mahmood, K., Joo, J. E., Makalic, E., Clendenning, M., Como, J., Preston, S., Joseland, S. L., Pope, B. J., et al. (2022) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2022.10.003 · Cited by 13

Papillary thyroid carcinoma (PTC) in Lynch syndrome: Report of two cases and discussion on Lynch syndrome behaviour and genetics

Pelizzo, M. R., Pennelli, G., Zane, M., Galuppini, F., Colletti, P. M., Boschin, I. M., & Rubello, D. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.06.008 · Cited by 13

Predisposition to colorectal cancer: exploiting copy number variation to identify novel predisposing genes and mechanisms

Venkatachalam, R., Ligtenberg, M. J. L., Hoogerbrugge, N., van Kessel, A. G., & Kuiper, R. P. (2008) · Cytogenetic and Genome Research · doi:10.1159/000184708 · Cited by 13

Making Sense of Missense in Lynch Syndrome: The Clinical Perspective

Lynch, H. T., Jascur, T. A., Lanspa, S. J., & Boland, C. R. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0204 · Cited by 13

Methylation Analysis of DNA Mismatch Repair Genes Using DNA Derived from the Peripheral Blood of Patients with Endometrial Cancer: Epimutation in Endometrial Carcinogenesis

Takeda, T., Banno, K., Yanokura, M., Adachi, M., Iijima, M., Kunitomi, H., Nakamura, K., Iida, M., Nogami, Y., Umene, K., et al. (2016) · Genes · doi:10.3390/genes7100086 · Cited by 13

In Silico Systems Biology Analysis of Variants of Uncertain Significance in Lynch Syndrome Supports the Prioritization of Functional Molecular Validation

Borràs, E., Chang, K., Pande, M., Cuddy, A., Bosch, J. L., Bannon, S. A., Mork, M. E., Rodrı́guez-Bigas, M. A., Taggart, M. W., Lynch, P. M., et al. (2017) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-17-0058 · Cited by 13

EPCAM germline and somatic rearrangements in lynch syndrome: identification of a novel 3′EPCAM deletion

Spaepen, M., Neven, E., Sagaert, X., Hertogh, G. D., Beert, E., Wimmer, K., Matthijs, G., Legius, E., & Brems, H. (2013) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22080 · Cited by 13

Antisense Rnas And Epigenetic Regulation

Cui, I. H., & Cui, H. (2010) · Epigenomics · doi:10.2217/epi.09.46 · Cited by 13

Identification of a founder EPCAM deletion in Spanish Lynch syndrome families

Mur, P., Pineda, M., Romero, A., Valle, J. D., Borràs, E., Canal, A., Navarro, M., Brunet, J., Rueda, D., y Cajal, T. R., et al. (2013) · Clinical Genetics · doi:10.1111/cge.12152 · Cited by 13

Young age and a positive family history of colorectal cancer are complementary selection criteria for the identification of Lynch syndrome

Manders, P., Spruijt, L., Kets, C. M., Willems, H. W., Bodmer, D., Hebeda, K. M., Nagtegaal, I. D., van Krieken, J. H., Ligtenberg, M. J. L., & Hoogerbrugge, N. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.12.024 · Cited by 13

Methylation marks in blood DNA reveal breast cancer risk in patients fulfilling hereditary disease criteria

la Cruz, M. R.-D., Martínez-Gregorio, H., Díaz-Velásquez, C. E., Ambriz-Barrera, F., Resendiz-Flores, N. G., Gitler-Weingarten, R., Rojo-Castillo, M. P., Pradda, D., Oliver, J., Perdomo, S. P., et al. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00611-z · Cited by 13

Rare germline copy number variants in colorectal cancer predisposition characterized by exome sequencing analysis

Franch‐Expósito, S., Esteban-Jurado, C., Garré, P., Quintanilla, I., Durán-Sanchón, S., Díaz‐Gay, M., Bonjoch, L., Cuatrecasas, M., Samper, E., Muñoz, J., et al. (2017) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2017.12.001 · Cited by 12

MLH1 promoter hypermethylation: are you absolutely sure about the absence of MLH1 germline mutation? About a new case

Kientz, C., Prieur, F., Clémenson, A., Joly, M., Stachowicz, M., Auclair, J., Attignon, V., Schiappa, R., & Wang, Q. (2019) · Familial Cancer · doi:10.1007/s10689-019-00151-7 · Cited by 12

Downregulation of ORP3 Correlates with Reduced Survival of Colon Cancer Patients with Advanced Nodal Metastasis and of Female Patients with Grade 3 Colon Cancer

Xu, P., Richter, J., Blatz, A., Gärtner, F., Alberts, R., Azoitei, A., Makori, W. A., Meessen, S., Knippschild, U., & Güneş, Ç. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165894 · Cited by 12

Cytoplasmic MSH2 Related to Genomic Deletions in the MSH2/EPCAM Genes in Colorectal Cancer Patients With Suspected Lynch Syndrome

Lin, D., Zou, S., Jin, X., Lu, H., Zhang, Y., Guo, L., Cai, J., & Ying, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.627460 · Cited by 12

Easy‐to‐use online referral test detects most patients with a high familial risk of colorectal cancer

Dekker, N., Hermens, R., Mensenkamp, A. R., van Zelst–Stams, W. A. G., & Hoogerbrugge, N. (2013) · Colorectal Disease · doi:10.1111/codi.12407 · Cited by 12

Aberrant DNA Methylation and Epigenetic Inactivation of hMSH2 Decrease Overall Survival of Acute Lymphoblastic Leukemia Patients via Modulating Cell Cycle and Apoptosis

Wang, C., Wang, X., Liu, H.-B., & Zhou, Z. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.1.355 · Cited by 12

Evidence of response to pembrolizumab in a patient with Lynch syndrome-related metastatic colon cancer

Salman, P., Panay, S., Fernández, R., Mauricio Mahave, C., & Soza‐Ried, C. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s167645 · Cited by 12

Toward a better definition of EPCAM deletions in Lynch Syndrome: Report of new variants in Italy and the associated molecular phenotype

Cini, G., Quaia, M., Canzonieri, V., Fornasarig, M., Maestro, R., Morabito, A., D'Elia, A. V., Urso, E. D. L., Mammi, I., & Viel, A. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.587 · Cited by 12

Development of an MSI-positive colon tumor with aberrant DNA methylation in a PPAP patient

Yamaguchi, K., Shimizu, E., Yamaguchi, R., Imoto, S., Komura, M., Hatakeyama, S., Noguchi, R., Takane, K., Ikenoue, T., Gohda, Y., et al. (2019) · Journal of Human Genetics · doi:10.1038/s10038-019-0611-7 · Cited by 12

Targeted next generation sequencing screening of Lynch syndrome in Tunisian population

Sghaier, R. B., Jansen, A. M. L., Bdioui, A., van Wezel, T., Ksiaa, M., Elgolli, L., Fatma, L. B., Ahmed, S. B., Azzouz, M. M., Hellara, O., et al. (2019) · Familial Cancer · doi:10.1007/s10689-019-00130-y · Cited by 12

Lynch Syndrome in Urologic Malignancies – What Does the Urologist Need to Know?

Goldberg, H., Wallis, C. J. D., Klaassen, Z. W. A., Chandrasekar, T., Fleshner, N. E., & Zlotta, A. R. (2019) · Urology · doi:10.1016/j.urology.2019.07.004 · Cited by 12

Cell cycle–related genes as modifiers of age of onset of colorectal cancer in Lynch syndrome: a large-scale study in non-Hispanic white patients

Chen, J., Pande, M., Huang, Y.-J., Wei, C., Amos, C. I., Talseth‐Palmer, B. A., Meldrum, C. J., Chen, W. V., Gorlov, I. P., Lynch, P. M., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs344 · Cited by 12

Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome Patients

Jansen, A. M. L., Geilenkirchen, M. A., van Wezel, T., Jagmohan–Changur, S., Ruano, D., van der Klift, H. M., van den Akker, B. E. W. M., Laros, J. F. J., van Galen, M., Wagner, A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157381 · Cited by 12

Novel insights on the positive correlation between sense and antisense pairs on gene expression

Das, S., Rojas, M. P. Z., & Tran, E. J. (2024) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1864 · Cited by 11

Role of the microenvironment in the tumourigenesis of microsatellite unstable and MUTYH-associated polyposis colorectal cancers

de Miranda, N. F. C. C., Hes, F. J., van Wezel, T., & Morreau, H. M. (2012) · Mutagenesis · doi:10.1093/mutage/ger077 · Cited by 11

An Update on Inherited Colon Cancer and Gastrointestinal Polyposis

Plevová, P. (2019) · Klinicka onkologie · doi:10.14735/amko2019s97 · Cited by 11

New clinicopathological concept of endometrial carcinoma with integration of histological features and molecular profiles

Yasuda, M. (2024) · Pathology International · doi:10.1111/pin.13471 · Cited by 11

Sequence Variants of Uncertain Significance

Greenblatt, M. S. (2015) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2015.06.009 · Cited by 11

Alu in Lynch Syndrome: A Danger SINE?

Hitchins, M. P., & Burn, J. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0417 · Cited by 11

Current applications of molecular pathology in colorectal carcinoma

González, R. S., Washington, K. M., & Shi, C. (2017) · Applied cancer research/Applied Cancer Research · doi:10.1186/s41241-017-0020-1 · Cited by 11

Management of Non-Colorectal Digestive Cancers with Microsatellite Instability

Zhu, M., Jin, Z., & Hubbard, J. M. (2021) · Cancers · doi:10.3390/cancers13040651 · Cited by 11

Is it all Lynch syndrome?: An assessment of family history in individuals with mismatch repair–deficient tumors

Dempsey, K. M., Broaddus, R. R., You, Y. N., Noblin, S. J., Mork, M. E., Fellman, B. M., Urbauer, D. L., Daniels, M., & Lu, K. H. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.131 · Cited by 11

Evaluation of a nationwide Dutch guideline to detect Lynch syndrome in patients with endometrial cancer

Tjalsma, A. S., Wagner, A., Dinjens, W. N. M., Ewing-Graham, P., Alcala, L. A., de Groot, M. E. R., Hamoen, K. E., van Hof, A. C., Hofhuis, W., Hofman, L. N., et al. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.12.028 · Cited by 11

Lynch Syndrome-Associated Endometrial Cancer With Combined EPCAM-MSH2 Deletion: A Case Report

Huang, R., Deng, X., Zhang, Z., Wen, Q., & Li, D. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.856452 · Cited by 10

Microsatellite instability in stage II colorectal cancer: An Indian perspective

Rathore, A., Dubey, A., Vishwanath, S., Pathi, N., & Pathak, A. (2016) · Indian Journal of Cancer · doi:10.4103/0019-509x.204772 · Cited by 10

Historical review of Lynch syndrome

Wolf, A. I., Buchanan, A. H., & Farkas, L. M. (2013) · Journal of Coloproctology · doi:10.1590/s2237-93632013000200010 · Cited by 10

2023 Canadian Urological Association guideline: Genetic testing in prostate cancer

Rendon, R., Selvarajah, S., Wyatt, A. W., Kolinsky, M. P., Schrader, K. A., Fleshner, N. E., Kinnaird, A. S., Merrimen, J. L., Niazi, T. M., Fred Saad, C., et al. (2023) · Canadian Urological Association Journal · doi:10.5489/cuaj.8588 · Cited by 14

Therapeutic biomarkers in metastatic castration-resistant prostate cancer: does the state matter?

Slootbeek, P. H. J., Tolmeijer, S. H., Mehra, N., & Schalken, J. A. (2023) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2023.2266482 · Cited by 12

Role of cGAS-STING in colorectal cancer: A new window for treatment strategies

Khorasani, M. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156422 · Cited by 10

A pilot study comparing protein expression in different segments of the normal colon and rectum and in normal colon versus adenoma in patients with Lynch syndrome

Wei, C., Chen, J., Pande, M., Lynch, P. M., & Frazier, M. L. (2013) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-013-1437-x · Cited by 10

Mechanisms of Gastrointestinal Malignancies

Katona, B. W., & Lynch, J. P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00066-9 · Cited by 11

A genetic variant in telomerase reverse transcriptase (TERT) modifies cancer risk in Lynch syndrome patients harbouring pathogenic MSH2 variants

Wiik, M. U., Evans, T., Belhadj, S., Bolton, K. A., Dymerska, D., Jagmohan–Changur, S., Capellá, G., Kurzawski, G., Wijnen, J., Valle, L., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-90501-2 · Cited by 10

Integrative Analysis of Hereditary Nonpolyposis Colorectal Cancer: the Contribution of Allele-Specific Expression and Other Assays to Diagnostic Algorithms

Lellis, L. D., Aceto, G. M., Curia, M. C., Catalano, T., Mammarella, S., Veschi, S., Fantini, F., Battista, P., Stigliano, V., Messerini, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081194 · Cited by 10

Copy number variants associated with 18p11.32, DCC and the promoter 1B region of APC in colorectal polyposis patients

Masson, A. L., Talseth‐Palmer, B. A., Evans, T., McElduff, P., Spigelman, A. D., Hannan, G. N., & Scott, R. J. (2015) · Meta Gene · doi:10.1016/j.mgene.2015.12.005 · Cited by 10

Risk-reduction surgery in pediatric surgical oncology: A perspective

Sandoval, J. A., Fernández‐Pineda, I., & Malkan, A. D. (2016) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2016.01.004 · Cited by 12

Interpretation of Genetic Testing for Lynch Syndrome in Patients With Putative Familial Colorectal Cancer

Rybak, C., & Hall, M. J. (2011) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2011.0106 · Cited by 10

Functional analysis of MMR gene VUS from potential Lynch syndrome patients

Mahdouani, M., Zhuri̇, D., Guler, H. S., Hmida, D., Mokni, S., Azzaza, M., Saïd, M. B., Masmoudi, S., Hmila, F., Youssef, S., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0304141 · Cited by 9

Time to Think Outside the (Genetic) Box

Issa, J. J., & Garber, J. E. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0348 · Cited by 9

The Mutational Spectrum of Lynch Syndrome in Cyprus

Loizidou, M. A., Neophytou, I., Papamichael, D., Kountourakis, P., Vassiliou, V., Marcou, Y., Kakouri, E., Ioannidis, G., Philippou, C., Spanou, E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105501 · Cited by 9

Select Biomarkers for Tumors of the Gastrointestinal Tract: Present and Future

Bartley, A. N., & Hamilton, S. R. (2014) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2014-0189-ra · Cited by 9

Population epigenetics, ecotoxicology, and human diseases

Patkin, E. L., & Софронов, Г. А. (2013) · Russian Journal of Genetics Applied Research · doi:10.1134/s2079059713050079 · Cited by 9

Diet quality and colorectal tumor risk in persons with Lynch syndrome

Eijkelboom, A. H., Brouwer, J. G. M., Vasen, H. F. A., Bisseling, T. M., Koornstra, J. J., Kampman, E., & van Duijnhoven, F. J. B. (2020) · Cancer Epidemiology · doi:10.1016/j.canep.2020.101809 · Cited by 9

Cancer predisposition in pediatric neuro-oncology—practical approaches and ethical considerations

Hirsch, S., Dikow, N., Pfister, S. M., & Pajtler, K. W. (2021) · Neuro-Oncology Practice · doi:10.1093/nop/npab031 · Cited by 9

Current chemoprevention approaches in Lynch syndrome and Familial adenomatous polyposis: a global clinical practice survey

Mraz, K. A., Hodan, R., Rodgers, L., Arora, S., Balaguer, F., Guillem, J. G., Jeter, J., Kanth, P., Li, D., Liska, D., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1141810 · Cited by 9

Performance characteristics of a brief Family History Questionnaire to screen for Lynch syndrome in women with newly diagnosed endometrial cancer

Eiriksson, L. R., Aronson, M. D., Clarke, B. A., Mojtahedi, G., Massey, C., Oza, A. M., Gallinger, S., Pollett, A. F., MacKay, H. J., Bernardini, M. Q., et al. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.12.023 · Cited by 9

Hereditary diffuse gastric cancer: lifesaving total gastrectomy for CDH1 mutation carriers

Lynch, H. T., & Lynch, J. F. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2010.078170 · Cited by 9

Acceptance of Genetic Counseling and Testing in a Hospital‐Based Series of Patients with Gynecological Cancer

Dekker, N., van Dorst, E. B. L., van der Luijt, R. B., van Gijn, M. E., van Tuil, M. C., Offerhaus, G. J. A., & Ausems, M. G. E. M. (2012) · Journal of Genetic Counseling · doi:10.1007/s10897-012-9553-3 · Cited by 9

Identification of a Japanese Lynch syndrome patient with large deletion in the 3′ region of theEPCAMgene

Eguchi, H., Kumamoto, K., Suzuki, O., Kohda, M., Tada, Y., Okazaki, Y., & Ishida, H. (2015) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyv172 · Cited by 9

Colorectal Cancer in Australian Young Adults

Mikaeel, R. R., Price, T. J., Smith, E., Drew, P. A., Uylaki, W., Horsnell, M. E., & Young, J. P. (2019) · Mathews Journal of Cancer Science · doi:10.30654/mjcs.10018 · Cited by 10

Lynch Syndrome Testing

Pasche, B., Pennison, M. J., & DeYoung, B. R. (2016) · JAMA · doi:10.1001/jama.2016.8291 · Cited by 9

Metachronous colorectal cancer risks after extended or segmental resection in MLH1, MSH2, and MSH6 Lynch syndrome: multicentre study from the Prospective Lynch Syndrome Database

Database, P. L. S., Zalevskaja, K., Ojala, K., Petrov, A., Haupt, S., Sunde, L., Bernstein, I., Jenkins, M. A., Aretz, S., Nielsen, M., et al. (2025) · British journal of surgery · doi:10.1093/bjs/znaf061 · Cited by 8

How Can Next-Generation Sequencing (Genomics) Help Us in Treating Colorectal Cancer?

Ciombor, K. K., Haraldsdóttir, S., & Goldberg, R. M. (2014) · Current Colorectal Cancer Reports · doi:10.1007/s11888-014-0244-3 · Cited by 8

Follow-up recommendations and risk-reduction initiatives for Lynch syndrome

Guillén‐Ponce, C., Molina‐Garrido, M., & Carrato, A. (2012) · Expert Review of Anticancer Therapy · doi:10.1586/era.12.114 · Cited by 8

Colorectal cancer molecular profiling: from IHC to NGS in search of optimal algorithm

Furtado, L. V., & Samowitz, W. S. (2017) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-017-2153-8 · Cited by 8

The identification of Lynch syndrome in Congolese colorectal cancer patients

Poaty, H., Gandzion, C. A., Soubeyran, I., Gassaye, D., Peko, J. F., Bon, J. B. N., & Mbalawa, C. G. (2017) · Bulletin du Cancer · doi:10.1016/j.bulcan.2017.08.005 · Cited by 8

A germline mutation in Rab43 gene identified from a cancer family predisposes to a hereditary liver-colon cancer syndrome

Jiang, Y., Sun, Y., Hu, J., Yu, N., Liu, H., Fan, J., Ning, X., Li, Y., Liu, B., Sun, Y., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5845-4 · Cited by 8

Pre- and postassessment of nurse practitioners' knowledge of hereditary colorectal cancer

Edwards, Q. T., Maradiegue, A. H., Seibert, D. C., & Jasperson, K. W. (2011) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2011.00625.x · Cited by 8

Copy Number Variation in Hereditary Non-Polyposis Colorectal Cancer

Masson, A. L., Talseth‐Palmer, B. A., Evans, T., Grice, D. M., Duesing, K., Hannan, G. N., & Scott, R. J. (2013) · Genes · doi:10.3390/genes4040536 · Cited by 8

Functional Analysis in Mouse Embryonic Stem Cells Reveals Wild-Type Activity for Three Msh6 Variants Found in Suspected Lynch Syndrome Patients

Wielders, E., Houlleberghs, H., Isik, G., & Riele, H. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074766 · Cited by 8

Gene expression of the mismatch repair gene MSH2 in primary colorectal cancer

Jensen, L. H., Kuramochi, H., Crüger, D. G., Lindebjerg, J., Kølvraa, S., Danenberg, P. V., Danenberg, K. D., & Jakobsen, A. K. M. (2011) · Tumor Biology · doi:10.1007/s13277-011-0199-9 · Cited by 8

New EPCAM founder deletion in Polish population

Dymerska, D., Gołębiewska, K., Kuświk, M., Rudnicka, H., Scott, R. J., Billings, R., Pławski, A., Boruń, P., Siołek, M., Kozak‐Klonowska, B., et al. (2017) · Clinical Genetics · doi:10.1111/cge.13026 · Cited by 8

MLH1 intronic variants mapping to + 5 position of splice donor sites lead to deleterious effects on RNA splicing

Piñero, T. A., Soukarieh, O., Rolain, M., Álvarez, K., López-Köstner, F., Torrezan, G. T., Carraro, D. M., Nascimento, I., Bomfim, T. F., Machado-Lopes, T. M. B., et al. (2020) · Familial Cancer · doi:10.1007/s10689-020-00182-5 · Cited by 8

Genetic Factors

Walsh, M. F., Cadoo, K. A., Salo‐Mullen, E. E., Dubard-Gault, M. E., Stadler, Z. K., & Offit, K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00013-x · Cited by 10

Outcomes of endometrial cancer prevention strategies in patients with Lynch syndrome: a nationwide cohort study in the Netherlands

Eikenboom, E. L., van Leeuwen, L., Groenendijk, F. H., Woolderink, J. M., van Altena, A. M., van Leerdam, M. E., Spaander, M. C. W., van Doorn, H. C., Wagner, A., Breijer, M. C., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.103006 · Cited by 7

Molecular testing in colorectal cancer

Thomas, J. S., & Shi, C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-822824-1.00018-3 · Cited by 7

Laboratory Assays in Evaluation of Lynch Syndrome in Patients with Endometrial Carcinoma

Djordjevic, B., & Broaddus, R. R. (2016) · Surgical pathology clinics · doi:10.1016/j.path.2016.01.007 · Cited by 7

Haplotype analysis suggest that the MLH1 c.2059C > T mutation is a Swedish founder mutation

von Salomé, J., Liu, T., Keihäs, M., Morak, M., Holinski‐Feder, E., Berry, I. R., Moilanen, J. S., Baert‐Desurmont, S., Lindblom, A., & Lagerstedt‐Robinson, K. (2017) · Familial Cancer · doi:10.1007/s10689-017-0067-x · Cited by 7

The (not so) Controversial Role of DNA Methylation in Epigenetic Inheritance Across Generations

Irmler, M., Kaspar, D., de Angelis, M. H., & Beckers, J. (2020) · Springer eBooks · doi:10.1007/978-3-030-35213-4_10 · Cited by 7

Abstracts 3rd Biennial Meeting of InSiGHT (International Society for Gastrointestinal Hereditary Tumours)

Voorendt, M., Chan, T., Kuiper, R., Ligtenberg, M., Bodmer, D., Hoenselaar, E., Hendriks-Cornelissen, S., Hoogerbrugge, N., Brunner, H., Geurts van Kessel, A., et al. (2010) · Familial Cancer · doi:10.1007/s10689-010-9351-8

Potential Germline Epimutations in Lynch Syndrome: More Evidence for Genetics Superseding Epigenetics in Inactivation of DNA Mismatch Repair Genes in Hereditary Colorectal Cancer

Ebert, M. P. A., & Opitz, O. G. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.020 · Cited by 1

Silencing is Not‐So Golden: A New Model for Inheritance of Lynch Syndrome

Kobelka, C. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01199_1.x · Cited by 2

Frequency of Deletions of EPCAM (TACSTD1) in MSH2-Associated Lynch Syndrome Cases

Rumilla, K. M., Schowalter, K. V., Lindor, N. M., Thomas, B. C., Mensink, K. A., Gallinger, S., Holter, S., Newcomb, P. A., Potter, J. D., Jenkins, M. A., et al. (2011) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2010.11.011 · Cited by 100

EPCAM deletions and heritable MSH2 promoter methylation in Lynch syndrome

Kuiper, R. P., van Kessel, A. G., Venkatachalam, R., van Krieken, J. H., Hoogerbrugge, N., & Ligtenberg, M. J. L. (2010) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2010.07.031